A new recurrent point mutation in the COL1A2 gene was found in a patient wi
th type III osteogenesis imperfecta (OI). A G-to-T transversion in nucleoti
de position 1121 leads to an amino acid substitution Gly238Cys. This is the
first report on the most N-terminal cysteine substitution in COL1A2 report
ed so far. Until now, at this position, only serine substitutions were obse
rved five times in unrelated patients showing a highly variable expression
of OI. It is obvious that endogenic and/or exogenic modifiers are involved
in this classical autosomal dominant (or rarely recessive) mendelian disord
er. An apparent preferential substitution by cysteine and serine residues i
s discussed with reference to post-transcriptional or post-translational co
llagen assembly control.